Peptide binding characteristics of the coeliac disease-associated DQ(alpha10501, beta10201) molecule - PubMed (original) (raw)

Peptide binding characteristics of the coeliac disease-associated DQ(alpha1*0501, beta1*0201) molecule

Y van de Wal et al. Immunogenetics. 1996.

Abstract

Genetic susceptibility to coeliac disease (CD) is strongly associated with the expression of the HLA-DQ2 (alpha1(*)0501, beta1(*)0201) allele. There is evidence that this DQ2 molecule plays a role in the pathogenesis of CD as a restriction element for gliadin-specific T cells in the gut. However, it remains largely unclear which fragments of gliadin can actually be presented by the disease-associated DQ dimer. With a view to identifying possible CD-inducing antigens, we studied the peptide binding properties of DQ2. For this purpose, peptides bound to HLA-DQ2 were isolated and characterized. Dominant peptides were found to be derived from two self-proteins: in addition to several size-variants of the invariant chain (li)-derived CLIP peptide, a relatively large amount of an major histocompatibility complex (MHC) class I-derived peptide was found. Analogues of this naturally processed epitope (MHClalpha46 - 63) were tested in a cell-free peptide binding competition assay to investigate the requirements for binding to DQ2. First, a core sequence of 10 amino acids within the MHClalpha46 - 63 peptide was identified. By subsequent single amino acid substitution analysis of this core sequence, five putative anchor residues were identified at relative positions P1, P4, P6, P7, and P9. Replacement by the large, positively charged Lys at these positions resulted in a dramatic loss of binding. However, several other non-conservative substitutions had little or no discernable effect on the binding capacity of the peptides.

PubMed Disclaimer

Similar articles

• Both alpha and beta chain polymorphisms determine the specificity of the disease-associated HLA-DQ2 molecules, with beta chain residues being most influential.
  Johansen BH, Jensen T, Thorpe CJ, Vartdal F, Thorsby E, Sollid LM. Johansen BH, et al. Immunogenetics. 1996;45(2):142-50. doi: 10.1007/s002510050182. Immunogenetics. 1996. PMID: 8952964
• The peptide binding motif of the disease associated HLA-DQ (alpha 1* 0501, beta 1* 0201) molecule.
  Vartdal F, Johansen BH, Friede T, Thorpe CJ, Stevanović S, Eriksen JE, Sletten K, Thorsby E, Rammensee HG, Sollid LM. Vartdal F, et al. Eur J Immunol. 1996 Nov;26(11):2764-72. doi: 10.1002/eji.1830261132. Eur J Immunol. 1996. PMID: 8921967
• Unique peptide binding characteristics of the disease-associated DQ(alpha 1*0501, beta 1*0201) vs the non-disease-associated DQ(alpha 1*0201, beta 1*0202) molecule.
  van de Wal Y, Kooy YM, Drijfhout JW, Amons R, Papadopoulos GK, Koning F. van de Wal Y, et al. Immunogenetics. 1997;46(6):484-92. doi: 10.1007/s002510050309. Immunogenetics. 1997. PMID: 9321428
• Modelling of HLA-DQ2 and its interaction with gluten peptides to explain molecular recognition in celiac disease.
  Costantini S, Rossi M, Colonna G, Facchiano AM. Costantini S, et al. J Mol Graph Model. 2005 Apr;23(5):419-31. doi: 10.1016/j.jmgm.2004.12.002. Epub 2005 Jan 18. J Mol Graph Model. 2005. PMID: 15781184
• On the perils of poor editing: regulation of peptide loading by HLA-DQ and H2-A molecules associated with celiac disease and type 1 diabetes.
  Busch R, De Riva A, Hadjinicolaou AV, Jiang W, Hou T, Mellins ED. Busch R, et al. Expert Rev Mol Med. 2012 Jul 6;14:e15. doi: 10.1017/erm.2012.9. Expert Rev Mol Med. 2012. PMID: 22805744 Free PMC article. Review.

Cited by

• Celiac disease T-cell epitopes from gamma-gliadins: immunoreactivity depends on the genome of origin, transcript frequency, and flanking protein variation.
  Salentijn EM, Mitea DC, Goryunova SV, van der Meer IM, Padioleau I, Gilissen LJ, Koning F, Smulders MJ. Salentijn EM, et al. BMC Genomics. 2012 Jun 22;13:277. doi: 10.1186/1471-2164-13-277. BMC Genomics. 2012. PMID: 22726570 Free PMC article.
• Thermal and Acidic Treatments of Gluten Epitopes Affect Their Recognition by HLA-DQ2 in silico.
  Gao J, Du H, Zhou Z, Liang Z, Liang H, Zhang P, Wei X, Liu S, Fu L, Wang Y, Che H, Xue W, Xin F, Yang D. Gao J, et al. Front Nutr. 2021 May 19;8:647750. doi: 10.3389/fnut.2021.647750. eCollection 2021. Front Nutr. 2021. PMID: 34095188 Free PMC article.
• Structural basis for HLA-DQ2-mediated presentation of gluten epitopes in celiac disease.
  Kim CY, Quarsten H, Bergseng E, Khosla C, Sollid LM. Kim CY, et al. Proc Natl Acad Sci U S A. 2004 Mar 23;101(12):4175-9. doi: 10.1073/pnas.0306885101. Epub 2004 Mar 12. Proc Natl Acad Sci U S A. 2004. PMID: 15020763 Free PMC article.
• HLA-DQ2 and -DQ8 signatures of gluten T cell epitopes in celiac disease.
  Tollefsen S, Arentz-Hansen H, Fleckenstein B, Molberg O, Ráki M, Kwok WW, Jung G, Lundin KE, Sollid LM. Tollefsen S, et al. J Clin Invest. 2006 Aug;116(8):2226-36. doi: 10.1172/JCI27620. Epub 2006 Jul 27. J Clin Invest. 2006. PMID: 16878175 Free PMC article.
• The intestinal T cell response to alpha-gliadin in adult celiac disease is focused on a single deamidated glutamine targeted by tissue transglutaminase.
  Arentz-Hansen H, Körner R, Molberg O, Quarsten H, Vader W, Kooy YM, Lundin KE, Koning F, Roepstorff P, Sollid LM, McAdam SN. Arentz-Hansen H, et al. J Exp Med. 2000 Feb 21;191(4):603-12. doi: 10.1084/jem.191.4.603. J Exp Med. 2000. PMID: 10684852 Free PMC article.

References

1. 1. Int Immunol. 1994 Nov;6(11):1639-49 - PubMed
2. 1. J Exp Med. 1994 Aug 1;180(2):623-9 - PubMed
3. 1. J Exp Med. 1993 Jul 1;178(1):27-47 - PubMed
4. 1. Br J Rheumatol. 1991 Feb;30(1):5-9 - PubMed
5. 1. J Biol Chem. 1987 Nov 25;262(33):16087-94 - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Springer

• Other Literature Sources

  • The Lens - Patent Citations Database

• Medical

  • MedlinePlus Health Information

• Molecular Biology Databases

  • Immune Epitope Database and Analysis Resource

• Research Materials

  • NCI CPTC Antibody Characterization Program